Literature DB >> 20879087

Baseline factors associated with incident HIV and STI in four microbicide trials.

Paul J Feldblum1, Che-Chin Lie, Mark A Weaver, Lut Van Damme, Vera Halpern, Adesina Adeiga, Rashidi Bakare, Jill Schwartz, Marissa Becker, Suniti Solomon.   

Abstract

BACKGROUND: Analyzing pooled data from 4 recent microbicide trials, we aimed to determine characteristics of participants at higher risk of HIV and sexually transmitted infections (STIs), to inform targeted recruitment, preserved study power, and potentially smaller study sizes in future trials.
METHODS: We evaluated the relationships between participants' characteristics and the incidence of HIV, STIs, and reproductive tract infections (RTIs). We calculated incidence rates as the number of infection events divided by the person-years of observation. We applied Cox regression models to assess the relationships between baseline demographic, reproductive and behavioral factors and incident HIV, STIs and RTIs.
RESULTS: The pooled incidence rates for HIV, chlamydia, and gonorrhea were 2.1, 6.4 and 9.9 per 100 person-years, respectively. Proportions of participants with trichomoniasis, bacterial vaginosis (BV), and candidiasis were 0.06, 0.40, and 0.40, respectively. In final multivariable models, age and education were significantly (and inversely) associated with incident HIV; baseline chlamydia, baseline trichomoniasis, and younger age were associated with incident Chlamydia; and baseline gonorrhea infection, younger age, less education, nulliparous status, baseline chlamydia, and condom use for contraception were associated with incident gonorrhea. Three factors were associated with trichomoniasis: baseline trichomoniasis infection, baseline chlamydia, and baseline BV.
CONCLUSIONS: Only younger age was robustly associated with multiple STI outcomes in our multivariable analyses. Although there was little evidence of associations between baseline STIs and incident HIV, they were strongly associated with incident STIs. We found no evidence that measured baseline sexual behavior factors were associated with incident HIV or STIs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20879087

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  20 in total

1.  Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials.

Authors:  Gita Ramjee; Reshmi Dassaye; Tarylee Reddy; Handan Wand
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

2.  Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.

Authors:  Brandon L Guthrie; Andrea Introini; Alison C Roxby; Robert Y Choi; Rose Bosire; Barbara Lohman-Payne; Taha Hirbod; Carey Farquhar; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

3.  Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe.

Authors:  Sandra I McCoy; Lauren J Ralph; Nancy S Padian; Alexandra M Minnis
Journal:  AIDS Behav       Date:  2014-12

4.  Barriers of Mucosal Entry of HIV/SIV.

Authors:  Ann M Carias; Thomas J Hope
Journal:  Curr Immunol Rev       Date:  2019

5.  Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.

Authors:  Lynette J Menezes; Ubin Pokharel; Staci L Sudenga; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim van der Loeff; Louvina E van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano
Journal:  Sex Transm Infect       Date:  2017-05-10       Impact factor: 3.519

6.  Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3).

Authors:  Tara Henning; Yetunde Fakile; Christi Phillips; Elizabeth Sweeney; James Mitchell; Dorothy Patton; Gail Sturdevant; Harlan D Caldwell; W Evan Secor; John Papp; R Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2011-08       Impact factor: 0.667

7.  Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.

Authors:  Lauren J Ralph; Sandra I McCoy; Karen Shiu; Nancy S Padian
Journal:  Lancet Infect Dis       Date:  2015-01-09       Impact factor: 25.071

8.  Sexually transmitted infections among HIV-infected adults in HIV care programs in Kenya: a national sample of HIV clinics.

Authors:  Benson Singa; Sara Nelson Glick; Naomi Bock; Judd Walson; Linda Chaba; James Odek; R Scott McClelland; Gaston Djomand; Hongjiang Gao; Grace John-Stewart
Journal:  Sex Transm Dis       Date:  2013-02       Impact factor: 2.830

9.  Hepatitis C virus and human immunodeficiency virus transmission routes: Differences and similarities.

Authors:  Francesca Cainelli
Journal:  World J Hepatol       Date:  2013-05-27

10.  Chlamydia and Gonorrhea Infections in HIV-positive Women in Urban Lusaka, Zambia.

Authors:  Maria L Alcaide; Deborah L Jones; Ndashi Chitalu; Stephen Weiss
Journal:  J Glob Infect Dis       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.